Anthony Windebank
Professor of Neurology · Mayo Clinic College of Medicine and Science
Credentials: · · ·
History
- 1974–1975
General Medicine Swindon General Hospital
- 1970–1974
Doctor of Medicine
Research
Chemotherapy-induced peripheral neuropathy: A current review
Review · Annals of Neurology · 2017 · Last of 4 authors · 661 citations
Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome
Case report · New England Journal of Medicine · 1983 · 505 citations
Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
New England Journal of Medicine · 1995 · 458 citations
53 papers
34 papers · 20 as a resident
29 papers
24 papers · 9 as a resident
- NS
23 papers · 2 as a fellow
19 papers · 1 as a resident
- JD
17 papers
16 papers
Grants
- 2017–2027
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
National Center for Advancing Translational Sciences · TL1
Contact PI · $6M · Mayo Clinic Rochester
- 2008–2014
A Non-Secreted Form of IGF-1 Is a Protective Factor for Neural Stem Cells
National Institute on Aging · R01
Contact PI · $355.1K · Mayo Clinic Rochester
- 2000–2011
Mechanisms of Neuronal Death and Neuroprotection
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.5M · Mayo Clinic Rochester
- 2003–2007
Biodegradable Polymer Implants for Spinal Cord Repair
National Institute of Biomedical Imaging and Bioengineering · R01
Contact PI · $1.3M · Mayo Clinic Rochester
Clinical trials
- 2018–2027
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
Principal investigator · Active not recruiting
Mayo Clinic
- 2017–2026
Principal investigator · Active not recruiting · Phase 2
Mayo Clinic
- 2017–2020
Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients
Principal investigator · Completed · Phase 3
Brainstorm-Cell Therapeutics
- 2014–2016
Principal investigator · Completed · Phase 2
Brainstorm-Cell Therapeutics